» Articles » PMID: 24358069

The Effect of Socioeconomic Class and Immigrant Status on Disease Activity in Rheumatoid Arthritis: Data from BARFOT, a Multi-Centre Study of Early RA

Overview
Publisher Bentham Open
Specialty Rheumatology
Date 2013 Dec 21
PMID 24358069
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There have been no reports on the effect of immigrant status and socioeconomic status on outcome in rheumatoid arthritis (RA) in Sweden.

Methods: Between 1992 and 2006, 2,800 patients were included in the BARFOT study on early RA in Sweden. Disease Activity Score 28 joints (DAS28), Health Assessment Questionnaire (HAQ), treatment and European League Against Rheumatism (EULAR) response criteria were registered. In 2010, 1,430 patients completed a questionnaire enquiring about demographics and lifestyle factors.

Results: One hundred and thirty-nine of the 1,430 patients (9.7%) were immigrants. At baseline immigrants had higher mean HAQ (1.2 vs 0.97 for non-immigrants, p=0.001), DAS28 (5.6 vs 5.2, p=0.000), visual analog scale (VAS) pain (56 mm vs 45 mm, p=0.000), VAS global health (53 mm vs 44 mm, p=0.000) and tender joint count (TJC) (10 vs 8, p=0.000). These differences persisted for up to 2 years of follow-up (for HAQ, for up to 8 years of follow-up). Immigrant status did not have any effect on swollen joint count (SJC), ESR, CRP or EULAR response. Socioeconomic class did not have any effect on treatment or outcome.

Conclusions: Immigrants scored worse in pain, function and TJC for up to 2 years of follow-up, but they did not differ from non-immigrants in objective measures of inflammation or EULAR outcome. This could be due to different perceptions of health and pain and/or the stress of immigration. Socioeconomic class had no effect on treatment or outcome, and this could be due to the relatively egalitarian society in Sweden.

Citing Articles

Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review.

Dey M, Busby A, Elwell H, Lempp H, Pratt A, Young A RMD Open. 2022; 8(1).

PMID: 35450954 PMC: 9024227. DOI: 10.1136/rmdopen-2021-002058.


Evaluation of C-Reactive Protein and Associated Factors Among Patients Suffering from Rheumatoid Arthritis at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Dessie G, Tadesse Y, Demelash B, Genet S, Malik T, Dejenie T Open Access Rheumatol. 2021; 13:247-255.

PMID: 34456591 PMC: 8387308. DOI: 10.2147/OARRR.S325308.


Socio-demographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts.

Kumaradev S, Roux C, Sellam J, Perrot S, Pham T, Dugravot A Rheumatology (Oxford). 2021; 61(4):1496-1509.

PMID: 34270700 PMC: 8996788. DOI: 10.1093/rheumatology/keab562.


Effect of disease duration and prior disease-modifying antirheumatic drug use on treatment outcomes in patients with rheumatoid arthritis.

Aletaha D, Maa J, Chen S, Park S, Nicholls D, Florentinus S Ann Rheum Dis. 2019; 78(12):1609-1615.

PMID: 31434637 PMC: 6900248. DOI: 10.1136/annrheumdis-2018-214918.


Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review.

Gwinnutt J, Sharp C, Symmons D, Lunt M, Verstappen S Semin Arthritis Rheum. 2018; 48(3):384-398.

PMID: 29680162 PMC: 6562164. DOI: 10.1016/j.semarthrit.2018.03.004.


References
1.
. Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? ERAS Study Group. Early Rheumatoid Arthritis Study. Ann Rheum Dis. 2000; 59(10):794-9. PMC: 1752999. DOI: 10.1136/ard.59.10.794. View

2.
Andersson M, Bergman S, Soderlin M . The effect of snuff (smokeless tobacco) on disease activity and function in rheumatoid arthritis: experiences from the Better Anti-Rheumatic FarmacOTherapy, a longitudinal multicenter study on early rheumatoid arthritis. J Clin Rheumatol. 2013; 19(1):14-8. DOI: 10.1097/RHU.0b013e31828214ed. View

3.
Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B . Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004; 63(9):1090-5. PMC: 1755129. DOI: 10.1136/ard.2003.014233. View

4.
Soderlin M, Bergman S . Absent "Window of Opportunity" in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis. J Rheumatol. 2011; 38(10):2160-8. DOI: 10.3899/jrheum.100991. View

5.
Forslind K, Hafstrom I, Ahlmen M, Svensson B . Sex: a major predictor of remission in early rheumatoid arthritis?. Ann Rheum Dis. 2006; 66(1):46-52. PMC: 1798403. DOI: 10.1136/ard.2006.056937. View